Hawkmoth LLC – Trademark Portfolio

Entity Type: 16

Hawkmoth LLC has 6 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 5 are successfully registered — a 100% registration rate, with 1 application currently pending. The portfolio includes marks such as ARTERRA and EMERALD EYES. Filings span 3 Nice Classification classes, with the highest activity in Class 25 (Clothing) and Class 40 (Treatment & Processing). This trademark owner is based in Hume, VA.

11564 Putnams Mill Road

Hume, VA 22639

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EE
EE
Pending 2025
ARTERRA
ARTERRA
Registered 2013
ARTERRA
ARTERRA
Registered 2013
ARTERRA
ARTERRA
Registered 2013
ARTERRA
ARTERRA
Registered 2013

Trademark Classifications

Hawkmoth LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (2 filings)

Clothing, footwear, headgear

40
Treatment & Processing (2 filings)

Treatment of materials

33
Wine & Spirits (2 filings)

Alcoholic beverages (except beers)

Frequently Asked Questions

How many trademarks does Hawkmoth LLC have?

Hawkmoth LLC has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending.

What trademark classes does Hawkmoth LLC file in?

Hawkmoth LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 40 (Treatment & Processing), Class 33 (Wine & Spirits). Class 25 covers clothing, footwear, headgear.

What are Hawkmoth LLC's most well-known trademarks?

Hawkmoth LLC's registered trademark portfolio includes well-known marks such as ARTERRA and EMERALD EYES. These are among 5 currently registered trademarks in the portfolio.

What is Hawkmoth LLC's trademark registration success rate?

Hawkmoth LLC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.